Cart
sales@molnova.com
Valnoctamide
CAS No. 4171-13-5
Valnoctamide( —— )
Catalog No. M33528 CAS No. 4171-13-5
Valnoctamide (Valmethamide) has antiepileptic and anticonvulsant activity and can be used in the study of neurological disorders.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameValnoctamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionValnoctamide (Valmethamide) has antiepileptic and anticonvulsant activity and can be used in the study of neurological disorders.
-
DescriptionValnoctamide (Valmethamide), a derivative of valproate, suppresses benzodiazepine-refractory status epilepticus. Valnoctamide (Valmethamide) acts directly on GABAA receptors.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorGABA Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number4171-13-5
-
Formula Weight143.23
-
Molecular FormulaC8H17NO
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 100 mg/mL (698.18 mM)
-
SMILESO=C(N)C(CC)C(C)CC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Spampanato J, et al. Valnoctamide enhances phasic inhibition: a potential target mechanism for the treatment of benzodiazepine-refractory status epilepticus. Epilepsia. 2014 Sep;55(9):e94-8.?
molnova catalog
related products
-
Betulonic acid
Betulonic acid amide stimulated the regenerative response in hepatocytes under conditions of combined toxic exposure and promoted recovery of their qualitative and quantitative characteristics.
-
DS-2330
DS-2330 is a phosphorous lowering agent for treating hyperphosphatemia in chronic kidney disease.
-
Ginsenoside Rg5
Ginsenoside Rg5 could be a beneficial agent for the treatment of Alzheimer's disease.
